Endonovo Therapeutics, Inc.
ENDV
Revenue
1.52k
▼-43.68k▼-96.64%
3 Months ChangeAssets
815.76k
▼-199.06k▼-19.61%
3 Months ChangeLiabilities
23.78M
▲559.31k▲2.41%
3 Months ChangeFree Cash Flow
-599.72k
▼-599.72k-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-01-03
Form 8-K
ID: 0001493152-24-000339
2023-12-29
Form 10-Q
ID: 0001493152-23-046444
2023-12-04
Form 8-K
ID: 0001493152-23-043516
2023-10-12
Form 8-K
ID: 0001493152-23-036971
2023-08-21
Form 10-Q
ID: 0001493152-23-029706
2023-05-22
Form 10-Q
ID: 0001493152-23-018538
2023-03-29
Form 8-K
ID: 0001493152-23-009376
2022-11-21
Form 10-Q
ID: 0001493152-22-033118
2022-09-27
Form 8-K
ID: 0001493152-22-026882
2022-08-22
Form 10-Q
ID: 0001493152-22-023661